The 20 Best Pityriasis Rosea Doctors Near Me in Ann Arbor, MI

Elizabeth Spratt is a Dermatologist practicing medicine in Ann Arbor, Michigan. Dr. Spratt is rated as an Advanced provider by MediFind in the treatment of Pityriasis Rosea. She is also highly rated in 31 other conditions, according to our data. Her clinical expertise encompasses Actinic Keratosis, Melanoma, Giant Congenital Melanocytic Nevus, and Giant Congenital Nevus.

Dr. Maya Aravind is a board-certified dermatologist and Assistant Professor of Dermatology at the University of Michigan. She provides medical dermatology diagnosis and treatment to patients of all ages within in our medical dermatology outpatient clinics.Dr. Aravind received her medical degree from the University of Michigan Medical School, and her master of science degree in clinical research from the University of Michigan School of Public Health Rackham School of Graduate Studies. Following graduation, she completed her transitional year internship at Oakwood Hospital in Dearborn, MI, and her dermatology residency at the U-M Department of Dermatology. Dr. Aravind practiced dermatology in Tennessee and Texas before joining the clinical faculty of the University of Michigan Department of Dermatology in 2022. Dr. Aravind is rated as an Experienced provider by MediFind in the treatment of Pityriasis Rosea. She is also highly rated in 38 other conditions, according to our data. Her clinical expertise encompasses Actinic Keratosis, Melanoma, Warts, and Seborrheic Keratosis.

After receiving my M.D. and Ph.D. at the University of Alabama at Birmingham, I came to the University of Michigan for residency training in Anatomic Pathology. During my residency and subsequent Dermatopathology fellowship, I became interested in mechanistic studies of cutaneous and soft-tissue malignancies. Upon completion of my fellowship in June 2012, I accepted a faculty position at UMHS with joint appointments in the Departments of Dermatology and Pathology, in which I continue to investigate molecular events in the pathogenesis of Merkel cell carcinoma and other cutaneous malignancies, while maintaining clinical effort in dermatopathology and molecular dermatopathology. Dr. Harms is rated as an Experienced provider by MediFind in the treatment of Pityriasis Rosea. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Merkel Cell Carcinoma, Tieche-Jadassohn Nevus, Melanoma, and Sebaceous Adenoma. Dr. Harms is board certified in Pathology-Anatomic and Dermatopathology.

Dr. May Chan obtained her medical degree from the State University of New York at Buffalo and was a Howard Hughes Research Scholar in 2005-2006. She completed residency training in Anatomic Pathology at Beth Israel Deaconess Medical Center in Boston, followed by a Dermatopathology fellowship at Harvard. She joined the University of Michigan in 2011 and is now a Professor of Pathology and Dermatology. She is the Interim Section Head for Dermatopathology, the Program Director for the Dermatopathology Fellowship, and the Medical Director of the Immunohistochemistry Laboratory. She also serves on the Test Development and Advisory Committee of the American Board of Pathology.Dr. Chan is an editorial board member of Modern Pathology and Journal of Cutaneous Pathology. She has a broad research interest in the areas of inflammatory skin diseases, melanocytic lesions, cutaneous adnexal neoplasms, and immunohistochemistry. She is the author/co-author of over 90 peer-reviewed publications and the book, Handbook of Direct Immunofluorescence: A Pattern-based Approach to Skin and Mucosal Biopsies.Dr. Chan is board certified in Anatomic Pathology and Dermatopathology. In addition to her primary role as a dermatopathologist, Dr. Chan retains her interest in surgical pathology including interpretation of head and neck, soft tissue, pulmonary, and endocrine cases, as well as intraoperative frozen sections. Over the years she has been invited to speak at national and international meetings hosted by the United States and Canadian Academy of Pathology (USCAP), the American Society of Dermatopathology (ASDP), the College of American Pathologists (CAP), the American Society for Clinical Pathology (ASCP), the American Academy of Dermatology (AAD), the European Nail Society, and Dermpedia. Dr. Chan is rated as an Experienced provider by MediFind in the treatment of Pityriasis Rosea. She is also highly rated in 27 other conditions, according to our data. Her clinical expertise encompasses Melanoma, Basal Cell Skin Cancer, Sebaceous Adenoma, and Squamous Cell Skin Carcinoma.

Dr. Frank Wang, MD is a board-certified Dermatologist. He graduated from Stanford University and received his medical degree from Cornell University Medical College. Dr. Wang served his internship at the University of Pittsburgh Medical Center, and went on to complete a Fellowship and his Dermatology Residency here at the University of Michigan. In 2010, Dr. Wang joined the faculty at the University of Michigan Department of Dermatology. His interests and expertise include general clinical dermatology, and clinical and basic science research in the area of skin aging. Dr. Wang is rated as an Experienced provider by MediFind in the treatment of Pityriasis Rosea. He is also highly rated in 57 other conditions, according to our data. His clinical expertise encompasses Psoriasis, Actinic Keratosis, Pyoderma Gangrenosum, and Melanoma. Dr. Wang is board certified in Dermatology.

Dr. Yolanda Helfrich is a clinical professor of dermatology and the residency program director of the Department of Dermatology at the University of Michigan Medical School.Dr. Helfrich’s primary clinical focus is on medical dermatology. She has a special interest in rosacea, and has been invited to speak and write nationally about the pathogenesis and treatment of rosacea. She serves on the National Rosacea Society Medical Advisory Board. She also has a clinical specialization in the follow-up and diagnosis of high-risk skin cancer patients and runs a specialty clinic devoted to the care of patients with alopecia (hair loss).Throughout her career, Dr. Helfrich has had a strong interest in clinical research, and served as the Director of the Program for Clinical Research in Dermatology (PCRiD) in the department for 12 years. She has served as Primary Investigator on over 25 departmental and industry-sponsored clinical trials and research investigations of rosacea, atopic dermatitis, psoriasis, lichen planus, and other dermatologic conditions. She served on the Michigan Medicine Research Board of Directors Clinical Trials Subcommittee, with the key task of helping the institution create a unified clinical research enterprise, and subsequently served as one of the inaugural Medical Directors of the Neurosciences and Sensory Clinical Trials Support Unit. Dr. Helfrich embraces her role as an educator, and has served as the Residency Program Director in Dermatology since January 2016. She has worked hard to optimize the clinical training and educational environment for residents within the program. She was recently elected to the American Professors of Dermatology Program Directors Steering Committee. She also serves on the Michigan Medicine Graduate Medical Education Committee (GMEC). In 2015, she was elected to Michigan Medicine’s League of Educational Excellence, which honors instructional faculty for their extraordinary contributions to teaching and inspiring the next generation of Michigan physicians and scientists.Dr. Helfrich is a Michigan native. She grew up in Grayling and attended Grayling High School. She graduated with a B.A. in Latin and Ancient History from Swarthmore College in Pennsylvania. She subsequently attended medical school at the University of Michigan Medical School, graduating in 2001. Dr. Helfrich completed her internship in internal medicine and her residency in dermatology at the University of Michigan. She joined the faculty at the University of Michigan Department of Dermatology in 2. Dr. Helfrich is rated as an Experienced provider by MediFind in the treatment of Pityriasis Rosea. She is also highly rated in 52 other conditions, according to our data. Her clinical expertise encompasses Actinic Keratosis, Rosacea, Graham-Little-Piccardi-Lassueur Syndrome, and Melanoma. Dr. Helfrich is board certified in Dermatology.

Julia Chen is a primary care provider, practicing in Internal Medicine in Ann Arbor, Michigan. Dr. Chen is rated as an Experienced provider by MediFind in the treatment of Pityriasis Rosea. She is also highly rated in 22 other conditions, according to our data. Her clinical expertise encompasses COVID-19, Multisystem Inflammatory Syndrome in Children (MIS-C), Sinusitis, and Empyema. Dr. Chen is board certified in Internal Medicine.

Camilla Cascardo is a Dermatologist practicing medicine in Ann Arbor, Michigan. Dr. Cascardo is rated as an Experienced provider by MediFind in the treatment of Pityriasis Rosea. Her clinical expertise encompasses Comedones, Pyogenic Granuloma, Trichorrhexis Nodosa, and Roseola.

Allison Darland is a Dermatologist practicing medicine in Ann Arbor, Michigan. Dr. Darland is rated as an Experienced provider by MediFind in the treatment of Pityriasis Rosea. She is also highly rated in 34 other conditions, according to our data. Her clinical expertise encompasses Actinic Keratosis, Melanoma, Warts, and Sunburn.

Kristine Cece is a primary care provider, practicing in Family Medicine in Dexter, Michigan. Dr. Cece is rated as an Experienced provider by MediFind in the treatment of Pityriasis Rosea. Her clinical expertise encompasses Seasonal Affective Disorder (SAD), Familial Hypertension, Hypertension, and Glucocorticoid-Remediable Aldosteronism. Dr. Cece is board certified in Family Medicine.

Sonam Rama is a Dermatologist practicing medicine in Plymouth, Michigan. Dr. Rama is rated as an Experienced provider by MediFind in the treatment of Pityriasis Rosea. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Neurocutaneous Melanosis, Giant Congenital Nevus, Familial Atypical Multiple Mole Melanoma Syndrome, and Giant Congenital Melanocytic Nevus.